Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SHSSX vs. HRTS: which is better?

Bottom line

SHSSX vs HRTS: the short answer

SHSSX (Blackrock Health Sciences Opportunities Portfolio) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 61% by weight.

But SHSSX is far broader, holding 155 positions to 45 for HRTS, so beyond the top names it adds exposure HRTS doesn't have.

HRTS is cheaper at 0.75% vs 0.86% — a difference of $11 a year per $10,000 invested.

Over one year, HRTS returned +23.6% vs +16.3% for SHSSX.

Updated Nov 19, 2026

SHSSX vs HRTS side by side

SHSSXHRTS
TypeMutual fundETF
Fund familyBlackRockInnovator
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.86%0.75%
Annual cost per $10k$86$75
10-yr cost on $10k (prospectus)$1,061$1,168
Max front load0%None
12b-1 fee0%0%
1-yr return+16.3%+23.6%
5-yr return (annualized)+5.9%—
10-yr return (annualized)+9.8%—
Best quarter—+15.8%
Worst quarter—−12.4%
Net assets (fund)$5.9B$51.9M
Number of holdings15545
Portfolio turnover49%4%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

16 of SHSSX's top 25 holdings also appear in HRTS's top 25.

Shared top holdings
HoldingSHSSXHRTS
Eli Lilly & Company12.29%11.52%
Johnson & Johnson8.77%3.59%
Unitedhealth Group Inc6.10%5.24%
Merck & Company Inc4.94%4.27%
Gilead Sciences Inc4.19%3.43%
Abbvie Inc3.94%2.40%
Amgen Inc3.37%1.91%
Thermo Fisher Scientific Inc3.02%3.97%
Vertex Pharmaceuticals Inc2.74%2.93%
Edwards Lifesciences Corp2.51%1.75%
Danaher Corp2.00%2.66%
Abbott Laboratories1.97%2.61%
Teva Pharmaceutical Industries Ltd1.87%2.06%
Astrazeneca Plc1.21%4.00%
Revolution Medicines Inc0.96%3.33%

Source: SEC Form N-PORT

SHSSX top 10

  1. Eli Lilly & Company — 12.29%
  2. Johnson & Johnson — 8.77%
  3. Unitedhealth Group Inc — 6.10%
  4. Merck & Company Inc — 4.94%
  5. Gilead Sciences Inc — 4.19%
  6. Abbvie Inc — 3.94%
  7. Amgen Inc — 3.37%
  8. Thermo Fisher Scientific Inc — 3.02%
  9. Vertex Pharmaceuticals Inc — 2.74%
  10. Pfizer Inc — 2.61%

HRTS top 10

  1. Eli Lilly & Co — 11.52%
  2. UnitedHealth Group Inc — 5.24%
  3. Novo Nordisk A/S — 5.24%
  4. Roche Holding AG — 4.50%
  5. Merck & Co Inc — 4.27%
  6. AstraZeneca PLC — 4.00%
  7. Thermo Fisher Scientific Inc — 3.97%
  8. Johnson & Johnson — 3.59%
  9. Gilead Sciences Inc — 3.43%
  10. Novartis AG — 3.38%

FAQ

What is the difference between SHSSX and HRTS?
SHSSX (Blackrock Health Sciences Opportunities Portfolio) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 61% by weight. But SHSSX is far broader, holding 155 positions to 45 for HRTS, so beyond the top names it adds exposure HRTS doesn't have.
Which is cheaper, SHSSX or HRTS?
HRTS has the lower expense ratio (0.75%).
Should I own both SHSSX and HRTS?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.